Blood-based monitoring for all solid organ tumours
https://www.datarpgx.de/cancertrack/
CancerTrack is a blood-based analysis that detects cancer-related biomarkers with ultrahigh precision, specificity and reliability. CancerTrack enables continuous monitoring of the cancer to detect relapses or changes in the tumour characteristics at an early stage.
About CancerTrack
CancerTrack can be used to monitor the disease / recurrence or changes in the tumour characteristics, as often as necessary.
Features of CancerTrack:
- Detection of circulating DNA, which is released into the patient's blood by cancer cells (ctDNA); if necessary, in combination with circulating tumour cells (CTCs)
- Detection of tumour activity at an early stage
- Real-time adaption of the medication based on the test results
- Additionally: monitoring of non-visible metastases and tumours
- Limits of detection: 0.1% (Minor Allele Frequency)
- Secure, simple and cost-effective
CancerTrack is suitable for:
- every patient who is under treatment for cancer
- every person who has been diagnosed with cancer, as a supplement to conventional biopsy and imaging
- every patient who is in remission / a cancer survivor and needs monitoring.
Certifications/accreditations of Datar Cancer Genetics
